Company: PSTV
Filing Date: 2025-04-01
Form Type: PRER14A
Source: 0001140361-25-011649
Chunk: 12

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-04-01
Form: PRER14A
Chunk 12
---
ustherapeutics.com/reports-filings/quarterly-results. You can also view the Special Meeting materials at http://www.proxyvote.com by using the control number provided on your proxy card or the Notice.

<div align='center'>6</div>

TABLE OF CONTENTS

PROPOSAL 1: THE REVERSE STOCK SPLIT PROPOSAL Our Board has unanimously approved and declared advisable and is recommending that our stockholders approve and adopt a proposed amendment to our Certificate of Incorporation to combine the outstanding shares of our Common Stock into a lesser number of outstanding shares, in substantially the form attached hereto as Annex A, to effect a reverse stock split of all of our outstanding shares of Common Stock at a specific ratio within a range of one-for-twenty five (1-for-25) to a maximum of a one-for-two hundred fifty (1-for-250), (the “Reverse Stock Split”), with the final decision of whether to proceed with the Reverse Stock Split, the effective time of the Reverse Stock Split, and the exact ratio of the Reverse Stock Split to be determined by our Board, in its sole discretion and without further action by the Company’s stockholders; provided, however, that our Board will not select a reverse split ratio that will result in us having fewer than 500,000 publicly held shares under the Nasdaq continued listing standards. The following table contains approximate information relating to our Common Stock immediately following the Reverse Stock Split under certain possible exchange ratios, based on share information as of March 4, 2025 (all share numbers are rounded down to the nearest whole share):

|                                                                       |     |      Prior to 
       Reverse 
   Stock Split |     | Giving Effect to Reverse Stock Split at Ratio of: |     |             |     |             |     |             |     |             |     |             |
|                                                                       |     |      1-for-25 |     |                                          1-for-70 |     |   1-for-115 |     |   1-for-160 |     |   1-for-205 |     |   1-for-250 |     |             |
| Authorized shares of Common Stock                                     |     |   100,000,000 |     |                                       100,000,000 |     | 100,000,000 |     | 100,000,000 |     | 100,000,000 |     | 100,000,000 |     | 100,000,000 |
| Outstanding shares of Common